Sagility Ltd to Acquire Chirok Health for USD 32.35 Million

Aggregate purchase price is USD 32.35 million, with USD 20 million paid upfront.
Transaction expected to close on October 21, 2026, targeting US provider segment growth.

Reader Takeaway: The deal strengthens Sagility’s US provider services, though future payouts remain linked to specific performance milestones.

What just happened

Sagility (US) Holdings Inc., a wholly-owned subsidiary of Sagility Ltd, has signed a definitive agreement to acquire 100% of Chirok Health LLC. The acquisition is an all-cash transaction valued at up to USD 32.35 million. The closing is scheduled for October 21, 2026. The deal includes USD 20 million as an upfront payment, with the remaining USD 12.35 million structured as contingent consideration based on future performance targets.

Why this matters

This acquisition is a strategic move to deepen Sagility’s presence in the US healthcare provider market. Chirok Health specializes in Clinical Documentation Integrity (CDI), medical coding, and Revenue Cycle Management (RCM), utilizing its proprietary CHEMP workflow platform. By integrating these services, Sagility aims to enhance its existing portfolio and offer more comprehensive revenue optimization solutions to its healthcare clients.

Risks to watch

Investors should note the performance-linked nature of the deal. With nearly 38% of the consideration dependent on future milestones, the ultimate value of the acquisition depends on Chirok Health’s ability to meet operational targets post-acquisition. The company has confirmed this is not a related party transaction.

Context metrics

Chirok Health reported turnovers of USD 12.7 million in 2023, USD 8.2 million in 2024, and USD 9.0 million in 2025.